BACKGROUND: Obese ZSF-1 rats display many features of human type II diabetes including nephropathy (DN). The study aimed to further understand the relevance of this model to DN, for which glomerular filtration rate (GFR), renal fibrosis and several urinary/tissue biomarkers was followed over 24 weeks in ZSF-1 rats. METHODS: Intact/sham or uninephrectomized male and female ZSF-1 rats were studied. GFR was measured by transdermal clearance of fluorescein isothiocyanate-sinistrin. Urine was collected every 2-4 weeks for biomarker analysis. Renal tissue was examined histologically for fibrosis and for levels of inflammatory and fibrotic genes. RESULTS: Male obese ZSF-1 rats demonstrated metabolic syndrome and proteinuria. Female counterparts were hyperlipidemic with delayed proteinuria, but were not hyperglycemic. Kidney hyperfiltration was observed in male obese rats in weeks 2-4 after surgery, and subsequently declined to levels significantly lower than controls. Tubulointerstitial/glomerular fibrosis in male obese rats was significantly elevated by week 12 post surgery and continued to expand in the ensuing weeks, particularly in uninephrectomized rats. Female rats had less severe fibrosis. Except for epidermal growth factor which decreased, the levels of several key inflammatory, injury and fibrotic factors were elevated in both tissue (mRNA) and urine (protein) of male obese rats. CONCLUSION: Male obese ZSF-1 rats represent an important DN model, manifesting key pathophysiological features including metabolic syndrome, proteinuria, progressive tubular and glomerular fibrosis, and transient hyperfiltration followed by progressive decline in renal function. Uninephrectomy significantly accelerated disease progression. Females were less severe in disease manifestation. Several urinary and tissue biomarkers were identified in the male obese rats that tracked with disease progression.
BACKGROUND:Obese ZSF-1 rats display many features of humantype II diabetes including nephropathy (DN). The study aimed to further understand the relevance of this model to DN, for which glomerular filtration rate (GFR), renal fibrosis and several urinary/tissue biomarkers was followed over 24 weeks in ZSF-1 rats. METHODS: Intact/sham or uninephrectomized male and female ZSF-1 rats were studied. GFR was measured by transdermal clearance of fluorescein isothiocyanate-sinistrin. Urine was collected every 2-4 weeks for biomarker analysis. Renal tissue was examined histologically for fibrosis and for levels of inflammatory and fibrotic genes. RESULTS: Male obese ZSF-1 rats demonstrated metabolic syndrome and proteinuria. Female counterparts were hyperlipidemic with delayed proteinuria, but were not hyperglycemic. Kidney hyperfiltration was observed in male obeserats in weeks 2-4 after surgery, and subsequently declined to levels significantly lower than controls. Tubulointerstitial/glomerular fibrosis in male obeserats was significantly elevated by week 12 post surgery and continued to expand in the ensuing weeks, particularly in uninephrectomized rats. Female rats had less severe fibrosis. Except for epidermal growth factor which decreased, the levels of several key inflammatory, injury and fibrotic factors were elevated in both tissue (mRNA) and urine (protein) of male obeserats. CONCLUSION: Male obese ZSF-1 rats represent an important DN model, manifesting key pathophysiological features including metabolic syndrome, proteinuria, progressive tubular and glomerular fibrosis, and transient hyperfiltration followed by progressive decline in renal function. Uninephrectomy significantly accelerated disease progression. Females were less severe in disease manifestation. Several urinary and tissue biomarkers were identified in the male obeserats that tracked with disease progression.
Authors: Ken Dower; Shanrong Zhao; Franklin J Schlerman; Leigh Savary; Gabriela Campanholle; Bryce G Johnson; Li Xi; Vuong Nguyen; Yutian Zhan; Matthew P Lech; Ju Wang; Qing Nie; Morten A Karsdal; Federica Genovese; Germaine Boucher; Thomas P Brown; Baohong Zhang; Bruce L Homer; Robert V Martinez Journal: PLoS One Date: 2017-07-26 Impact factor: 3.240
Authors: Brian N Chorley; Heidrun Ellinger-Ziegelbauer; Michael Tackett; Frank J Simutis; Alison H Harrill; James McDuffie; Elnaz Atabakhsh; Rounak Nassirpour; Laurence O Whiteley; Jean-François Léonard; Gleta K Carswell; Ernie Harpur; Connie L Chen; Jean-Charles Gautier Journal: Toxicol Sci Date: 2021-02-26 Impact factor: 4.849
Authors: Longfei Wang; Gunner Halliday; Joshua R Huot; Taijyu Satoh; Jeffrey J Baust; Amanda Fisher; Todd Cook; Jian Hu; Theodore Avolio; Dmitry A Goncharov; Yang Bai; Rebecca R Vanderpool; Robert V Considine; Andrea Bonetto; Jiangning Tan; Timothy N Bachman; Andrea Sebastiani; Charles F McTiernan; Ana L Mora; Roberto F Machado; Elena A Goncharova; Mark T Gladwin; Yen-Chun Lai Journal: Arterioscler Thromb Vasc Biol Date: 2020-04-09 Impact factor: 8.311
Authors: Md Abdul Hye Khan; Sung Hee Hwang; Scott D Barnett; Anna Stavniichuk; Wojciech K Jankiewicz; Bruce D Hammock; John D Imig Journal: Br J Pharmacol Date: 2021-08-12 Impact factor: 8.739
Authors: Inês Preguiça; André Alves; Sara Nunes; Pedro Gomes; Rosa Fernandes; Sofia D Viana; Flávio Reis Journal: Nutrients Date: 2020-01-18 Impact factor: 5.717
Authors: LaTonya J Hickson; Tala Abedalqader; Gift Ben-Bernard; Jayla M Mondy; Xiaohui Bian; Sabena M Conley; Xiangyang Zhu; Sandra M Herrmann; Aleksandra Kukla; Elizabeth C Lorenz; Seo Rin Kim; Bjorg Thorsteinsdottir; Lilach O Lerman; M Hassan Murad Journal: Stem Cells Transl Med Date: 2021-06-09 Impact factor: 6.940